Artificial intelligence (AI) startup company Paige.AI has been granted Breakthrough Device designation by the U.S. Food and Drug Administration (FDA) for its AI designed to enhance the clinical diagnosis and treatment of cancer. It is the first such designation for AI in cancer diagnosis publicly announced by any company, according to Paige.AI.

March 8, 2019 — Imaging Technology News (ITN) was named a finalist in multiple categories across print, web and other ...

Hologic Inc. announced the granting of a CE Mark to the LOCalizer wireless radio frequency identification (RFID) breast lesion localization system. This system is designed for precise and easy marking and targeting of lesions for breast-conserving surgery guidance.

With the passage of HB1124, South Dakota becomes the 37th state with breast density inform legislation. The law, which was signed on March 5, 2019 by Gov. Kristi Noem, goes into effect July 1, 2019.

U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb, M.D., resigned from his position March 5 after two years on the job, but said he plans to stay on with the agency into April. According to several major news outlets, the primary reason for Gottlieb’s resignation is so that he can spend more time with his family at home in Connecticut; he had reportedly been commuting to Washington, D.C., throughout his tenure.

The American College of Radiology (ACR) is one of seven professional societies behind a new consensus document on the ethics of using artificial intelligence (AI) in radiology. The authors are taking comments on the draft guidance through April 15, 2019, and a finalized document will be produced within the following six months.